PATTERN OF ADVERSE DRUG REACTION ASSOCIATED TO ANTIPSYCHOTIC DRUGS WITH SPECIAL REFERENCE TO HYPONATRAEMIA IN MEDICAL COLLEGE, KOLKATA: AN OBSERVATIONAL, CROSS-SECTIONAL STUDY

Main Article Content

Dr. Suhena Sarkar
Dr.Roshni Banerjee
Dr.Papia Sen
Dr.Arpita Bain
Dr Birupaksha Biswas

Keywords

Hyponatremia, Antipsychotics, Risperidone, Olanzapine, Aripiprazole, SIADH, Electrolyte Disturbance, Pharmacovigilance, Geriatric Psychiatry, Serum Sodium, Adverse Drug Reaction.

Abstract

The therapeutic armamentarium for psychotic spectrum disorders has undergone a profound metamorphosis with the advent of antipsychotic pharmacotherapeutics. The evolution from classical first-generation dopamine D2 antagonists, such as haloperidol and chlorpromazine, to more receptor-diverse second-generation antipsychotics (SGAs) including risperidone, olanzapine, and aripiprazole, has redefined the neuropsychopharmacology paradigm²˒³˒²². However, this progress has not been without the collateral burden of a diverse array of adverse drug reactions (ADRs), which complicate long-term clinical management, impede compliance, and potentiate iatrogenic morbidity

Abstract 112 | Pdf Downloads 4

References

1. Uchiyama M, et al. Hyponatremia secondary to psychotropic medications: a systematic review. J Clin Psychopharmacol. 2018;38(5):443-450.
2. Falhammar H, et al. Antipsychotic-associated hyponatremia in the Swedish population: a nationwide case-control study. J Psychopharmacol. 2018;32(12):1308-1316.
3. Sahoo S, et al. Hyponatremia in elderly psychiatric patients: clinical and pharmacological implications. Asian J Psychiatr. 2016;21:17-22.
4. Stachnik JM, et al. The syndrome of inappropriate antidiuretic hormone (SIADH) in psychiatry: pharmacologic associations and management strategies. US Pharm. 2024;49(3):HS11-HS16.
5. Dube D, et al. Olanzapine-induced SIADH: a case report and review of literature. Rev Colomb Psiquiatr. 2020;49(4):277-282.
6. Guo Y, et al. Pharmacodynamic profiles of atypical antipsychotics and hyponatremia risk. Psychopharmacology. 2021;238(2):451-463.
7. Spigset O. Mechanisms of psychotropic drug-induced SIADH. Acta Psychiatr Scand. 1994;89(6):451-459.
8. Ayus JC, et al. Chronic hyponatremia in the elderly: associations with falls, fractures, and mortality. Am J Med. 2013;126(12):1127-1133.
9. Babar SM, et al. Hyponatremia and the geriatric syndrome: a review. Curr Geriatr Rep. 2018;7(1):1-7.
10. Rahman M, et al. Early-onset hyponatremia with risperidone: clinical pharmacology and outcomes. Clin Neuropharmacol. 2010;33(2):105-108.
11. Sköldunger A, et al. Antipsychotics and electrolyte disorders: a pharmacoepidemiological perspective. J Clin Med. 2020;9(4):1144.
12. Lin CH, et al. Delayed-onset hyponatremia in elderly patients with schizophrenia. Int Psychogeriatr. 2011;23(3):461-468.
13. Yamamoto K, et al. Aripiprazole and SIADH: case-based evidence. Clin Psychopharmacol Neurosci. 2008;6(3):157-160.
14. Filippatos TD, et al. Electrolyte and acid–base disorders in psychiatric illness: pathophysiology and clinical implications. World J Psychiatr. 2016;6(1):1-10.
15. Ayus JC, et al. Neurologic sequelae of hyponatremia in elderly populations. Neurology. 2000;54(3):1305-1312.
16. Verbalis JG, et al. Pathogenesis of hyponatremia: vasopressin and water homeostasis. Am J Med. 2013;126(10 Suppl 1):S1-S7.
17. Miller M. Hyponatremia and bone health in the elderly. J Clin Endocrinol Metab. 2006;91(4):1229-1233.
18. Renneboog B, et al. Mild chronic hyponatremia is associated with falls and fractures in elderly. Am J Med. 2006;119(1):71.e1-71.e8.
19. Liamis G, et al. Hyponatremia in clinical practice: causes, implications, and management. Eur J Intern Med. 2008;19(6):407-413.
20. Spasovski G, et al. Clinical practice guideline on diagnosis and treatment of hyponatremia. Nephrol Dial Transplant. 2014;29 Suppl 2:i1-i39.
21. Naranjo CA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239-245.
22. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356(9237):1255-1259.
23. Leung AA, et al. Drug-induced SIADH: a review. QJM. 2008;101(8):569-575.
24. Balestrieri M, et al. Hyponatremia associated with antipsychotics: evidence from pharmacovigilance data. Drug Saf. 2012;35(6):481-488.
25. Movig KLL, et al. Hyponatremia associated with antidepressants and antipsychotics. Pharmacoepidemiol Drug Saf. 2002;11(8):689-694.
26. Hix JK, et al. Diagnosing SIADH: essential and emerging tests. Am Fam Physician. 2006;73(5):769-776.
27. Miyamoto S, et al. D2/D3 receptor blockade and clinical psychopharmacology. J Psychopharmacol. 2005;19(4):403-419.
28. Remington G, et al. Receptor affinity and side effect profiles of antipsychotics. Can J Psychiatry. 2006;51(10):631-643.